Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Natrix Separations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013925
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through polish applications; and bind-elute products in downstream bind-elute operations. Natrix supplies multi-cycle disposable chromatography products for life science, food, beverage and water markets. The company HD membrane technology offers breakthrough in membrane architecture that changes downstream purification. It markets products through a network of distributors in Europe, North America and Asia. Natrix Separation is headquartered in Burlington, Ontario, Canada.

Natrix Separations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Acquisition 11
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc – Key Competitors 13
Natrix Separations Inc – Key Employees 14
Natrix Separations Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Natrix Separations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc, Key Competitors 13
Natrix Separations Inc, Key Employees 14

★海外企業調査レポート[Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioCryst Pharmaceuticals Inc (BCRX)-製薬・医療分野:企業M&A・提携分析
    Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrat …
  • Insurance Australia Group Limited:企業の戦略・SWOT・財務情報
    Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Australia Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Uppsala University:企業のM&A・事業提携・投資動向
    Uppsala University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uppsala University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Great Bear Resources Ltd (GBR):企業の財務・戦略的SWOT分析
    Summary Great Bear Resources Ltd (GBRL) formerly Great Bear Uranium Corp, is a metals and mining company that offers minerals exploration and development services. The company acquires, mines, extracts, manages, explores, operates, produces, and develops uranium, gold, silver, base metals, and miner …
  • Saudi Airlines Catering:企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • Nordex SE (NDX1):電力:M&Aディール及び事業提携情報
    Summary Nordex SE (Nordex) is an integrated supplier of onshore wind turbine systems. It develops, produces, services and markets wind power systems. The company develops and produces complete systems, including the control software and main core components, and offers related services. Nordex serve …
  • Versantis AG-製薬・医療分野:企業M&A・提携分析
    Summary Versantis AG (Versantis), is a preclinical stage pharmaceutical company which offers new medicines and diagnostics for treating liver diseases. It’s lead pipeline product VS-01, capable of removing toxic agents from the organism and save patients from prescription and illicit drug overdoses. …
  • Prima Meat Packers Ltd:企業の戦略・SWOT・財務分析
    Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report Summary Prima Meat Packers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mr. Price Group Ltd.:戦略・SWOT・企業財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Engie Energia Chile SA (ECL):企業の財務・戦略的SWOT分析
    Engie Energia Chile SA (ECL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fidelity National Financial Inc:企業の戦略・SWOT・財務情報
    Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity National Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Frontline Ltd (FRO):企業の財務・戦略的SWOT分析
    Frontline Ltd (FRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MEDICREA Group (ALMED):企業の財務・戦略的SWOT分析
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • PetroChina Company Limited:企業の戦略・SWOT・財務分析
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Institut Curie-製薬・医療分野:企業M&A・提携分析
    Summary Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biolog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆